Grants and Contributions:

Title:
Op Grant: Sex as a Biological Variable Supplement: COVID-19 Rapid Research FO
Agreement Number:
155796
Agreement Value:
$50,000.00
Agreement Date:
May 1, 2020 - Apr 30, 2021
Description:
This supplement builds on the objectives of the first Operating Grant: Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity with a specific focus on: Uncovering novel molecular and cellular mechanisms that contribute to the sex differences observed in COVID-19 severity.
Organization:
Canadian Institutes of Health Research
Expected Results:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Location:
Toronto, Ontario, CA M5B 1W8
Reference Number:
236-2020-2021-Q1-01140
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Zhang, Haibo
Research Organization:
Unity Health Toronto
Program:
Research in Priority Areas
Program Purpose:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.